Bristol Myers Squibb CELG-RI
NYSE CELG-RI
$0.11 +0.00 (+0.00%)
As of: Sep 9, 2026 · 2:55 PM EDT

Bristol Myers Squibb (CELG-RI) Dividend Coverage Ratio (2009 - 2026)

Bristol Myers Squibb's (CELG-RI) quarterly Dividend Coverage Ratio came in at 2.58 in Q2 2026, up 147.65% year-over-year from 1.04 in Q2 2025, and up 23.39% quarter-over-quarter from 2.09 in Q1 2026.

Analysis

Bristol Myers Squibb (CELG-RI) Dividend Coverage Ratio (2009 - 2026) Analysis & Trends

Bristol Myers Squibb (CELG-RI) has reported Dividend Coverage Ratio for 18 consecutive years, with 2.58 the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Dividend Coverage Ratio rose 147.65% year-over-year to 2.58 in Q2 2026; TTM through Jun 2026 was 1.82, a 78.04% increase from a year earlier, with the FY2025 full-year figure at 1.4, up 176.14% from the prior year.
  • Dividend Coverage Ratio was 2.58 for Q2 2026 at Bristol Myers Squibb, up from 2.09 in the prior quarter.
  • Over five years, Dividend Coverage Ratio peaked at 119.08 in Q2 2022 and troughed at 9.83 in Q1 2024.
  • A 5-year average of 7.39 and a median of 1.57 in 2023 frame the typical range for Dividend Coverage Ratio.
  • Across the five-year window, Dividend Coverage Ratio sank 618.34% in 2024 and soared 1279.13% in 2025, its largest moves.
  • Over 5 years, Dividend Coverage Ratio stood at 1.77 in 2022, then dropped by 14.11% to 1.52 in 2023, then slumped by 95.89% to 0.06 in 2024, then soared by 1279.13% to 0.86 in 2025, then jumped by 199.41% to 2.58 in 2026.
  • The last three Dividend Coverage Ratio figures came in at 2.58 (Q2 2026), 2.09 (Q1 2026), and 0.86 (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Div. Cover (Qtr)
1 Johnson & Johnson 663.08 Bn 642.33 Bn 17.26 Bn 1.71
2 AbbVie 453.04 Bn 446.51 Bn 12.70 Bn 1.18
3 Merck 370.87 Bn 363.78 Bn 12.21 Bn -0.62
4 Novartis Ag 305.29 Bn 298.00 Bn 11.24 Bn 1.14
5 Pfizer 162.10 Bn 150.70 Bn 10.94 Bn -0.10
6 Sanofi 53.95 Bn 46.98 Bn 10.79 Bn 0.07
7 Revolution Medicines 45.00 Bn 45.00 Bn - -
8 Incyte 25.47 Bn 20.94 Bn 1.57 Bn -
9 United Therapeutics 20.81 Bn 18.15 Bn 683.80 Mn -
10 Bristol Myers Squibb 285.98 Mn -10.78 Bn 9.25 Bn 2.58
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.58
Mar 31, 2026 2.09
Dec 31, 2025 0.86
Sep 30, 2025 1.74
Jun 30, 2025 1.04
Mar 31, 2025 1.96
Dec 31, 2024 0.06
Sep 30, 2024 1.00
Jun 30, 2024 1.38
Mar 31, 2024 -9.83
Dec 31, 2023 1.52
Sep 30, 2023 1.62
Jun 30, 2023 1.74
Mar 31, 2023 1.90
Dec 31, 2022 1.77
Sep 30, 2022 1.39
Jun 30, 2022 119.08
Mar 31, 2022 1.08
Dec 31, 2021 2.16
Sep 30, 2021 1.42